Article
LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 Agonism.
Frontiers in immunology - 1 Jan 2022
Sudan Raki, Fernandes Sandra, Srivastava Neetu, Pedicone Chiara, Meyer Shea T, Chisholm John D, Engelman Robert W, Kerr William G
Abstract excerpt
Humans homozygous for inactivating LRBA (lipopolysaccharide (LPS)-responsive beige-like anchor) mutations or with compound heterozygous mutations exhibit a spectrum of immune-related pathologies including inflammatory bowel disease (IBD). The cause of this pathology remains undefined. Here we show that disruption of the colon epithelial barrier in LRBA-deficient mice by dextran sulfate sodium (DSS) consumption...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
